PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h

PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h

Abstract Background [18F]PSMA-1007 is a prostate specific membrane antigen (PSMA) ligand for positron emission tomography (PET) imaging of prostate cancer. Current guidelines recommend imaging 90–120 min after injection but strong data about optimal timing is lacking. Our aim was to study whether im...

Full description

Bibliographic Details
Main Authors: Erland Hvittfeldt, Ulrika Bitzén, David Minarik, Jenny Oddstig, Berit Olsson, Elin Trägårdh
Format: Article
Language:English
Published: SpringerOpen 2023-05-01
Series:European Journal of Hybrid Imaging
Subjects:
[18F]PSMA-1007
Prostate cancer
Uptake time
PET/CT
PSMA
Online Access:https://doi.org/10.1186/s41824-023-00167-4

Internet

https://doi.org/10.1186/s41824-023-00167-4

Similar Items